STK39 |
HSPH1 |
||
---|---|---|---|
Gene Name | serine threonine kinase 39 | heat shock 105kDa/110kDa protein 1 | |
Image | No pdb structure | No pdb structure | |
Gene Ontology Annotations | Cellular Component | ||
Molecular Function | |||
Biological Process |
|
||
Pathways | |||
Drugs | |||
Diseases | |||
GWAS | |||
Protein-Protein Interactions | 13 interactors: AATK GSN HSPH1 MAPK14 MBP OTOF PRKCQ RELT SLC12A1 SLC12A2 SLC12A6 SPP1 WNK4 | 14 interactors: ADD1 CFL1 CHD3 CSNK2A1 CSNK2A2 DYNLRB1 HSPA8 PAFAH1B1 PAFAH1B3 PGK1 STK39 TUBA4A UBA1 VAV2 | |
Entrez ID | 27347 | 10808 | |
HPRD ID | 09627 | 09990 | |
Ensembl ID | ENSG00000198648 | ENSG00000120694 | |
Uniprot IDs | Q9UEW8 | B4DYH1 Q92598 | |
PDB IDs | |||
Enriched GO Terms of Interacting Partners? |
|
|
|
Tagcloud ? | atp2b1
atxn2
bdkrb2
cacnb2
csk
cyp171a
cyp17a1
cyp1a2
eh
gwas
hfe
jan
meant
mthfr
nppa
nppb
nt5c2
overlapped
pharmacogenomics
plcd3
plekha7
sh2b3
tbx3
tbx5
ulk3
ulk4
umod
wnk4
znf652
|
accordingly
aggressive
aggressiveness
bcl
candidacy
clarify
concurrently
confirming
delay
favors
hodgkin
injected
interacts
lymphoma
lymphomas
myc
namalwa
nhl
nhls
oncoproteins
paralleled
physically
positively
silenced
stabilization
tumorigenicity
valuable
|
|
Tagcloud (Difference) ? | atp2b1
atxn2
bdkrb2
cacnb2
csk
cyp171a
cyp17a1
cyp1a2
eh
gwas
hfe
jan
meant
mthfr
nppa
nppb
nt5c2
overlapped
pharmacogenomics
plcd3
plekha7
sh2b3
tbx3
tbx5
ulk3
ulk4
umod
wnk4
znf652
|
accordingly
aggressive
aggressiveness
bcl
candidacy
clarify
concurrently
confirming
delay
favors
hodgkin
injected
interacts
lymphoma
lymphomas
myc
namalwa
nhl
nhls
oncoproteins
paralleled
physically
positively
silenced
stabilization
tumorigenicity
valuable
|
|
Tagcloud (Intersection) ? |